Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2015
Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
J Tie, I Kinde, Y Wang, et al.
Cancer Treatment and Research Communications
|
June 17, 2024
Early onset metastatic colorectal cancer in Australia
A Jalali, S Smith, G Kim, et al.
Current Problems in Cancer
|
September 27, 2021
Initial experience of TAS-102 chemotherapy in Australian patients with Chemo-refractory metastatic colorectal cancer
A Jalali, G Gard, S Banks, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Real-world characteristics and outcomes of patients with BRAF<sup>V600E</sup>-mutant metastatic colorectal cancer in Australia: the COALA project
N Hitchen, H-L Wong, R Wong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2017
Prognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studies
U-P Rohr, P Herrmann, K Ilm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2022
ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group
J Pascual, G Attard, F-C Bidard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 29, 2019
Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer
B Lee, L Lipton, J Cohen, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2015
Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
J Tie, I Kinde, Y Wang, et al.
Cancer Treatment and Research Communications
|
June 17, 2024
Early onset metastatic colorectal cancer in Australia
A Jalali, S Smith, G Kim, et al.
Current Problems in Cancer
|
September 27, 2021
Initial experience of TAS-102 chemotherapy in Australian patients with Chemo-refractory metastatic colorectal cancer
A Jalali, G Gard, S Banks, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Real-world characteristics and outcomes of patients with BRAF<sup>V600E</sup>-mutant metastatic colorectal cancer in Australia: the COALA project
N Hitchen, H-L Wong, R Wong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2017
Prognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studies
U-P Rohr, P Herrmann, K Ilm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2022
ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group
J Pascual, G Attard, F-C Bidard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 29, 2019
Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer
B Lee, L Lipton, J Cohen, et al.
Page
of 4